Axsome Therapeutics (NASDAQ:AXSM) Earns “Buy” Rating from Needham & Company LLC
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $153.00 price target on the stock. Needham & Company LLC’s target price indicates a potential upside of 21.84% from […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $153.00 price target on the stock. Needham & Company LLC’s target price indicates a potential upside of 21.84% from […]
